2-190056055-C-G

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBA1

The NM_005259.3(MSTN):​c.*1203G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.069 in 151,908 control chromosomes in the GnomAD database, including 856 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.069 ( 856 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MSTN
NM_005259.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.32
Variant links:
Genes affected
MSTN (HGNC:4223): (myostatin) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein negatively regulates skeletal muscle cell proliferation and differentiation. Mutations in this gene are associated with increased skeletal muscle mass in humans and other mammals. [provided by RefSeq, Jul 2016]
C2orf88 (HGNC:28191): (chromosome 2 open reading frame 88) Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 2-190056055-C-G is Benign according to our data. Variant chr2-190056055-C-G is described in ClinVar as [Benign]. Clinvar id is 333219.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MSTNNM_005259.3 linkuse as main transcriptc.*1203G>C 3_prime_UTR_variant 3/3 ENST00000260950.5 NP_005250.1
C2orf88XM_047446008.1 linkuse as main transcriptc.-517-23899C>G intron_variant XP_047301964.1
C2orf88XM_047446009.1 linkuse as main transcriptc.-517-23899C>G intron_variant XP_047301965.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MSTNENST00000260950.5 linkuse as main transcriptc.*1203G>C 3_prime_UTR_variant 3/31 NM_005259.3 ENSP00000260950 P1
C2orf88ENST00000478197.1 linkuse as main transcriptn.220-23168C>G intron_variant, non_coding_transcript_variant 4
C2orf88ENST00000495546.1 linkuse as main transcriptn.202-23899C>G intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0689
AC:
10455
AN:
151790
Hom.:
853
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0456
Gnomad ASJ
AF:
0.0620
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.00748
Gnomad FIN
AF:
0.000851
Gnomad MID
AF:
0.0355
Gnomad NFE
AF:
0.0170
Gnomad OTH
AF:
0.0633
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
432
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
260
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0690
AC:
10478
AN:
151908
Hom.:
856
Cov.:
32
AF XY:
0.0663
AC XY:
4925
AN XY:
74270
show subpopulations
Gnomad4 AFR
AF:
0.198
Gnomad4 AMR
AF:
0.0455
Gnomad4 ASJ
AF:
0.0620
Gnomad4 EAS
AF:
0.00155
Gnomad4 SAS
AF:
0.00749
Gnomad4 FIN
AF:
0.000851
Gnomad4 NFE
AF:
0.0170
Gnomad4 OTH
AF:
0.0626
Alfa
AF:
0.00592
Hom.:
6
Bravo
AF:
0.0784
Asia WGS
AF:
0.0140
AC:
48
AN:
3448

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Myostatin-related muscle hypertrophy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
11
DANN
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3187415; hg19: chr2-190920781; API